Intestinal Rehabilitation Therapy in Short Bowel Syndrome_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

ZHANG Mingming , WU Xiaoting

Department of General Surgery， West China Hospital， Sichuan University， Chengdu 610041， China;

Corresponding author：

Keywords：

Short bowel syndrome; Rehabilitation; Nutrition

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To investigate the role of rehabilitation therapy both on nutritional status and intestinal adaptation of patients with short bowel syndrome (SBS).
Methods 　The literatures about rehabilitation therapy for SBS were reviewed.
Results 　Intestinal rehabilitation refers to the process of restoring enteral autonomy, in order to get rid of parenteral nutrition, usually by means of dietary, medical, and surgical treatment. Recent researches showed that medication and the use of specific nutrients and growth factors could stimulate intestinal absorption and might be useful in the medical management of SBS.
Conclusion 　Intestinal rehabilitation is of benefit in the treatment of SBS and would play a greater role in the future.

Citation： ZHANG Mingming,WU Xiaoting. Intestinal Rehabilitation Therapy in Short Bowel Syndrome. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2007, 14(1): 117-119. doi: Copy

1.	Byrne TA, Morrissey TB, Nattakom TV, et al. Growth hormone, glutamine, and a modified diet enhance nutrient absorption in patients with severe short bowel syndrome [J]. JPEN J Parenter Enteral Nutr， 1995; 19(4)∶296.
2.	Wilmore DW. Growth factors and nutrients in the short bowel syndrome [J]. JPEN J Parenter Enteral Nutr， 1999; 23(5 Suppl)∶S117.
3.	Byrne TA, Cox S, Karimbakas M, et al. Bowel rehabilitation: an alternative to long-term parenteral nutrition and intestinal transplantation for some patients with short bowel syndrome [J]. Transplant Proc， 2002; 34(3)∶887.
4.	Nehra V, Camilleri M, Burton D, et al. An open trial of octreotide long-acting release in the management of short bowel syndrome [J]. Am J Gastroenterol， 2001; 96(5)∶1494.
5.	McDoniel K, Taylor B, Huey W, et al. Use of clonidine to decrease intestinal fluid losses in patients with high-output short-bowel syndrome [J]. JPEN J Parenter Enteral Nutr， 2004; 28(4)∶265.
6.	Gruy-Kapral C, Little KH, Fordtran JS, et al. Conjugated bile acid replacement therapy for short-bowel syndrome [J]. Gastroenterology， 1999; 116(1)∶15.
7.	Piena-Spoel M, Sharman-Koendjbiharie M, Yamanouchi T, et al. “Gut-feeling” or evidence-based approaches in the evaluation and treatment of human short-bowel syndrome [J]. Pediatr Surg Int， 2000; 16(3)∶155.
8.	Keating GM, Wellington K. Somatropin (Zorbtive): in short bowel syndrome [J]. Drugs， 2004; 64(12)∶1375.
9.	Seguy D, Vahedi K, Kapel N, et al. Low-dose growth hormone in adult home parenteral nutrition-dependent short bowel syndrome patients: a positive study [J]. Gastroenterology， 2003; 124(2)∶293.
10.	Dechelotte P, Darmaun D, Rongier M, et al. Absorption and metabolic effects of enterally administered glutamine in humans [J]. Am J Physiol， 1991; 260(5 Pt 1)∶G677.
11.	Perez A, Duxbury M, Rocha FG, et al. Glucagon-like peptide 2 is an endogenous mediator of postresection intestinal adaptation [J]. JPEN J Parenter Enteral Nutr， 2005; 29(2)∶97.
12.	Jeppesen PB, Hartmann B, Thulesen J, et al. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon [J]. Gastroenterology， 2001; 120(4)∶806.
13.	Haderslev KV, Jeppesen PB, Hartmann B, et al. Short-term administration of glucagon-like peptide-2. Effects on bone mineral density and markers of bone turnover in short-bowel patients with no colon [J]. Scand J Gastroenterol， 2002; 37(4)∶392.
14.	Jeppesen PB. ALX-0600, a dipeptidyl peptidase-Ⅳ resistant GLP-2 analog, improves intestinal function in short bowel syndrome patients with a jejunostomy [J]. Gastroenterology， 2002； 122∶AS1249.
15.	Thompson JS. Epidermal growth factor and the short bowel syndrome [J]. JPEN J Parenter Enteral Nutr， 1999; 23(5 Suppl)∶S113.
16.	Weiming Z, Ning L, Jieshou L. Effect of recombinant human growth hormone and enteral nutrition on short bowel syndrome [J]. JPEN J Parenter Enteral Nutr， 2004; 28(6)∶377.
17.	Scolapio JS. Current update of short-bowel syndrome [J]. Curr Opin Gastroenterol， 2004; 20(2)∶143.
18.	Scolapio JS, Camilleri M, Fleming CR, et al. Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study [J]. Gastroenterology， 1997; 113(4)∶1074.
19.	Szkudlarek J, Jeppesen PB, Mortensen PB. Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomised, double blind, crossover, placebo controlled study [J]. Gut， 2000; 47(2)∶199.
20.	Kim HB, Fauza D, Garza J, et al. Serial transverse enteroplasty (STEP): a novel bowel lengthening procedure [J]. J Pediatr Surg， 2003; 38(3)∶425.
21.	Javid PJ, Kim HB, Duggan CP, et al. Serial transverse enteroplasty is associated with successful short-term outcomes in infants with short bowel syndrome [J]. J Pediatr Surg， 2005; 40(6)∶1019.

1. 　Byrne TA, Morrissey TB, Nattakom TV, et al. Growth hormone, glutamine, and a modified diet enhance nutrient absorption in patients with severe short bowel syndrome [J]. JPEN J Parenter Enteral Nutr， 1995; 19(4)∶296.
2. 　Wilmore DW. Growth factors and nutrients in the short bowel syndrome [J]. JPEN J Parenter Enteral Nutr， 1999; 23(5 Suppl)∶S117.
3. 　Byrne TA, Cox S, Karimbakas M, et al. Bowel rehabilitation: an alternative to long-term parenteral nutrition and intestinal transplantation for some patients with short bowel syndrome [J]. Transplant Proc， 2002; 34(3)∶887.
4. 　Nehra V, Camilleri M, Burton D, et al. An open trial of octreotide long-acting release in the management of short bowel syndrome [J]. Am J Gastroenterol， 2001; 96(5)∶1494.
5. 　McDoniel K, Taylor B, Huey W, et al. Use of clonidine to decrease intestinal fluid losses in patients with high-output short-bowel syndrome [J]. JPEN J Parenter Enteral Nutr， 2004; 28(4)∶265.
6. 　Gruy-Kapral C, Little KH, Fordtran JS, et al. Conjugated bile acid replacement therapy for short-bowel syndrome [J]. Gastroenterology， 1999; 116(1)∶15.
7. 　Piena-Spoel M, Sharman-Koendjbiharie M, Yamanouchi T, et al. “Gut-feeling” or evidence-based approaches in the evaluation and treatment of human short-bowel syndrome [J]. Pediatr Surg Int， 2000; 16(3)∶155.
8. 　Keating GM, Wellington K. Somatropin (Zorbtive): in short bowel syndrome [J]. Drugs， 2004; 64(12)∶1375.
9. 　Seguy D, Vahedi K, Kapel N, et al. Low-dose growth hormone in adult home parenteral nutrition-dependent short bowel syndrome patients: a positive study [J]. Gastroenterology， 2003; 124(2)∶293.
10. 　Dechelotte P, Darmaun D, Rongier M, et al. Absorption and metabolic effects of enterally administered glutamine in humans [J]. Am J Physiol， 1991; 260(5 Pt 1)∶G677.
11. 　Perez A, Duxbury M, Rocha FG, et al. Glucagon-like peptide 2 is an endogenous mediator of postresection intestinal adaptation [J]. JPEN J Parenter Enteral Nutr， 2005; 29(2)∶97.
12. 　Jeppesen PB, Hartmann B, Thulesen J, et al. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon [J]. Gastroenterology， 2001; 120(4)∶806.
13. 　Haderslev KV, Jeppesen PB, Hartmann B, et al. Short-term administration of glucagon-like peptide-2. Effects on bone mineral density and markers of bone turnover in short-bowel patients with no colon [J]. Scand J Gastroenterol， 2002; 37(4)∶392.
14. 　Jeppesen PB. ALX-0600, a dipeptidyl peptidase-Ⅳ resistant GLP-2 analog, improves intestinal function in short bowel syndrome patients with a jejunostomy [J]. Gastroenterology， 2002； 122∶AS1249.
15. 　Thompson JS. Epidermal growth factor and the short bowel syndrome [J]. JPEN J Parenter Enteral Nutr， 1999; 23(5 Suppl)∶S113.
16. 　Weiming Z, Ning L, Jieshou L. Effect of recombinant human growth hormone and enteral nutrition on short bowel syndrome [J]. JPEN J Parenter Enteral Nutr， 2004; 28(6)∶377.
17. 　Scolapio JS. Current update of short-bowel syndrome [J]. Curr Opin Gastroenterol， 2004; 20(2)∶143.
18. 　Scolapio JS, Camilleri M, Fleming CR, et al. Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study [J]. Gastroenterology， 1997; 113(4)∶1074.
19. 　Szkudlarek J, Jeppesen PB, Mortensen PB. Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomised, double blind, crossover, placebo controlled study [J]. Gut， 2000; 47(2)∶199.
20. 　Kim HB, Fauza D, Garza J, et al. Serial transverse enteroplasty (STEP): a novel bowel lengthening procedure [J]. J Pediatr Surg， 2003; 38(3)∶425.
21. 　Javid PJ, Kim HB, Duggan CP, et al. Serial transverse enteroplasty is associated with successful short-term outcomes in infants with short bowel syndrome [J]. J Pediatr Surg， 2005; 40(6)∶1019.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Intestinal Rehabilitation Therapy in Short Bowel Syndrome

Abstract Full text Figures/Tables Video References Cited by

Format

Content